Glenmark Pharmaceuticals Ltd. NSE: GLENMARK | BSE: 532296

Strong Performer, Getting Expensive

Download real time

2127.70 -3.20 (-0.15%)

66.81% Gain from 52W Low

756.0K

NSE+BSE Volume

NSE 11 Sep, 2025 3:31 PM (IST)

Dividend

Glenmark Pharmaceuticals Ltd. has an upcoming dividend of ₹2.50 per share due on 15 Sep 2025 See details

Glenmark Pharmaceuticals Ltd. share price target

Glenmark Pharmaceuticals Ltd. has an average share price target of 2144. The consensus estimate represents an upside of 0.77% from the last price of 2127.70. View 11 reports from 5 analysts offering long-term price targets for Glenmark Pharmaceuticals Ltd..

Reco - This broker has downgraded this stock from it's previous report.
(eg. - Buy->Hold)

Target - Broker has maintained previous recommendation but reduced share price target.

Reco - This broker has upgraded this stock from it's previous report.
(eg. - Sell->Hold)

Target - Broker has maintained previous recommendation but increased share price target.

Load latest Google or static link led you to an intermediate page.

Click on any table column to sort reports by date, stock name, broker, price, target, upside or recommendation.

Summary	Date	Stock	Author	LTP	Target	Price at reco (Change since reco%)	Upside(%)	Type	Report		Discuss
	11 Sep 2025	Glenmark Pharma	Consensus Share Price Target	2127.70	2248.67	-	5.69	buy	pdf Detailed Estimates
	13 Feb 2023	Glenmark Pharma	Motilal Oswal	2127.70	420.00	422.60 (403.48%)	Target met	Neutral	pdf post cache		Broker Report Financial leverage/tax outweighs operational improvements Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	13 Feb 2023	Glenmark Pharma	ICICI Direct Target	2127.70	440.00	422.60 (403.48%)	Target met	Hold	pdf post cache		Broker Report Glenmark Pharma ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	21 Nov 2022	Glenmark Pharma	ICICI Direct Target	2127.70	470.00	422.40 (403.72%)	Target met	Hold	pdf post cache		Broker Report Glenmark Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	19 Nov 2022	Glenmark Pharma	Prabhudas Lilladhar Target	2127.70	460.00	411.65 (416.87%)	Target met	Accumulate	pdf post cache		Broker Report GLENMARK PHARMACEUTI Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
	17 Nov 2022	Glenmark Pharma	Motilal Oswal	2127.70	420.00	409.85 (419.14%)	Target met	Neutral	pdf post cache		Broker Report Working on many fronts to better outlook and return ratios Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	16 Aug 2022	Glenmark Pharma	ICICI Direct	2127.70	440.00	389.25 (446.62%)	Target met	Hold	pdf post cache		Broker Report Glenmark Pharmaceuticals ICICI Direct pdf Copy Link Share on Share on Share on Share on Alert
	15 Aug 2022	Glenmark Pharma	ICICI Securities Limited Reco Target	2127.70	478.00	388.80 (447.25%)	Target met	Buy	pdf post cache		Broker Report High base and weak US sales hit performance ICICI Securities Limited Glenmark Pharma’s (Glenmark) Q1FY23 performance missed our estimates. pdf Copy Link Share on Share on Share on Share on Alert
	13 Aug 2022	Glenmark Pharma	Motilal Oswal	2127.70	420.00	389.25 (446.62%)	Target met	Neutral	pdf post cache		Broker Report Steady traction exhibited in DF/ROW Motilal Oswal pdf Copy Link Share on Share on Share on Share on Alert
	07 Jun 2022	Glenmark Pharma	Geojit BNP Paribas Reco Target	2127.70	485.00	388.45 (447.74%)	Target met	Buy	pdf post cache		Broker Report GLENMARK PHARMACEUTICALS Geojit BNP Paribas pdf Copy Link Share on Share on Share on Share on Alert
	31 May 2022	Glenmark Pharma	Prabhudas Lilladhar Target	2127.70	450.00	389.10 (446.83%)	Target met	Accumulate	pdf post cache		Broker Report GLENMARK PHARMACEUTI Prabhudas Lilladhar pdf Copy Link Share on Share on Share on Share on Alert
more loading

* Please note that subscribers can download a maximum of 300 reports a month and 70 reports everyday.

Advisor Screeners